Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study

References

• Zhang B, Zhang B, Zhang Z, et al. 42,573 cases of hepatectomy in China: a multicenter retrospective investigation. Sci China Life Sci. 2018;61(6):660–670. doi:10.1007/s11427-017-9259-929417360
   PubMed Web of Science ®Google Scholar
• Meng KW, Dong M, Zhang WG, et al. Clinical characteristics and surgical prognosis of hepatocellular carcinoma with bile duct invasion. Gastroenterol Res Pract. 2014;2014:604971. doi:10.1155/2014/60497124723944
   PubMed Web of Science ®Google Scholar
• Shiomi M, Kamiya J, Nagino M, et al. Hepatocellular carcinoma with biliary tumor thrombi: aggressive operative approach after appropriate preoperative management. Surgery. 2001;129(6):692–698. doi:10.1067/msy.2001.11388911391367
   PubMed Web of Science ®Google Scholar
• Yang X, Qiu Z, Ran R, et al. Prognostic importance of bile duct invasion in surgical resection with curative intent for hepatocellular carcinoma using PSM analysis. Oncol Lett. 2018;16(3):3593–3602.30127966
   PubMed Web of Science ®Google Scholar
• Wang DD, Wu LQ, Wang ZS. Prognosis of hepatocellular carcinoma with bile duct tumor thrombus after R0 resection: a matched study. Hepatobiliary Pancreat Dis Int. 2016;15(6):626–632. doi:10.1016/S1499-3872(16)60143-127919852
   PubMed Web of Science ®Google Scholar
• Qiao W, Yu F, Wu L, et al. Surgical outcomes of hepatocellular carcinoma with biliary tumor thrombus: a systematic review. BMC Gastroenterol. 2016;16:11. doi:10.1186/s12876-016-0427-226822229
   PubMed Web of Science ®Google Scholar
• Pang YB, Zhong JH, Luo XL, et al. Clinicopathological characteristics and liver stem cell marker expression in hepatocellular carcinoma involving bile duct tumor thrombi. Tumour Biol. 2016;37(5):5879–5884. doi:10.1007/s13277-015-4446-326586401
   PubMedGoogle Scholar
• Orimo T, Kamiyama T, Yokoo H, et al. Hepatectomy for hepatocellular carcinoma with bile duct tumor thrombus, including cases with obstructive jaundice. Ann Surg Oncol. 2016;23(8):2627–2634. doi:10.1245/s10434-016-5174-727006124
   PubMed Web of Science ®Google Scholar
• Navadgi S, Chang CC, Bartlett A, et al. Systematic review and meta-analysis of outcomes after liver resection in patients with hepatocellular carcinoma (HCC) with and without bile duct thrombus. HPB (Oxford). 2016;18(4):312–316. doi:10.1016/j.hpb.2015.12.00327037199
   PubMed Web of Science ®Google Scholar
• Shao W, Sui C, Liu Z, et al. Surgical outcome of hepatocellular carcinoma patients with biliary tumor thrombi. World J Surg Oncol. 2011;9:2. doi:10.1186/1477-7819-9-221214943
   PubMed Web of Science ®Google Scholar
• An J, Lee KS, Kim KM, et al. Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion. Clin Mol Hepatol. 2017;23(2):160–169. doi:10.3350/cmh.2016.008828506055
   PubMed Web of Science ®Google Scholar
• Peng BG, Liang LJ, Li SQ, et al. Surgical treatment of hepatocellular carcinoma with bile duct tumor thrombi. World J Gastroenterol. 2005;11(25):3966–3969. doi:10.3748/wjg.v11.i25.396615991304
   PubMed Web of Science ®Google Scholar
• Moon DB, Hwang S, Wang HJ, et al. Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: a Korean multicenter study. World J Surg. 2013;37(2):443–451. doi:10.1007/s00268-012-1845-023188531
   PubMed Web of Science ®Google Scholar
• Wei W, Jian PE, Li SH, et al. Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety. Cancer Commun (Lond). 2018;38(1):61. doi:10.1186/s40880-018-0331-y30305149
   PubMedGoogle Scholar
• Wang Z, Ren Z, Chen Y, et al. Adjuvant transarterial chemoembolization for HBV-related hepatocellular carcinoma after resection: a randomized controlled study. Clin Cancer Res. 2018;24(9):2074–2081. doi:10.1158/1078-0432.CCR-17-289929420221
   PubMed Web of Science ®Google Scholar
• Zhong C, Guo RP, Li JQ, et al. A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma. J Cancer Res Clin Oncol. 2009;135(10):1437–1445. doi:10.1007/s00432-009-0588-219408012
   PubMed Web of Science ®Google Scholar
• Wang L, Ke Q, Deng M, et al. Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma after radical hepatectomy: a real world study. Scand J Gastroenterol. 2019;54(11):1403–1411. doi:10.1080/00365521.2019.168498631686555
   PubMed Web of Science ®Google Scholar
• Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954;7(3):462–503. doi:10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E13160935
   PubMed Web of Science ®Google Scholar
• Satoh S, Ikai I, Honda G, et al. Clinicopathologic evaluation of hepatocellular carcinoma with bile duct thrombi. Surgery. 2000;128(5):779–783. doi:10.1067/msy.2000.10865911056440
   PubMed Web of Science ®Google Scholar
• Chan AW, Chan SL, Wong GL, et al. Prognostic Nutritional Index (PNI) predicts tumor recurrence of very early/early stage hepatocellular carcinoma after surgical resection. Ann Surg Oncol. 2015;22(13):4138–4148. doi:10.1245/s10434-015-4516-125801356
   PubMed Web of Science ®Google Scholar
• Xie H, Tian S, Cui L, et al. Adjuvant trans-arterial chemoembolization after hepatectomy significantly improves the prognosis of low-risk patients with R0-stage hepatocellular carcinoma. Cancer Manag Res. 2019;11:4065–4073. doi:10.2147/CMAR.S19548531118814
   PubMed Web of Science ®Google Scholar
• Gao Z, Du G, Pang Y, et al. Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factors. Medicine (Baltimore). 2017;96(33):e7426. doi:10.1097/MD.000000000000742628816936
   PubMed Web of Science ®Google Scholar
• Tong Y, Li. Z, Liang Y, et al. Postoperative adjuvant TACE for patients of hepatocellular carcinoma in AJCC stage I: friend or foe? A propensity score analysis. Oncotarget. 2017;8(16):26671–26678. doi:10.18632/oncotarget.1579328460456
   PubMedGoogle Scholar
• Jiang JH, Guo Z, Lu HF, et al. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis. World J Gastroenterol. 2015;21(15):4627–4634. doi:10.3748/wjg.v21.i15.462725914472
   PubMed Web of Science ®Google Scholar
• Kuang X, Ye J, Xie Z, et al. Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection. Oncol Lett. 2018;16(4):4937–4944.30214612
   PubMed Web of Science ®Google Scholar
• Cheng HY, Wang X, Chen D, et al. The value and limitation of transcatheter arterial chemoembolization in preventing recurrence of resected hepatocellular carcinoma. World J Gastroenterol. 2005;11(23):3644–3646. doi:10.3748/wjg.v11.i23.364415962394
   PubMed Web of Science ®Google Scholar
• Song P, Inagaki Y, Wang Z, et al. High levels of gamma-glutamyl transferase and indocyanine green retention rate at 15 min as preoperative predictors of tumor recurrence in patients with hepatocellular carcinoma. Medicine (Baltimore). 2015;94(21):e810. doi:10.1097/MD.000000000000081026020384
   PubMed Web of Science ®Google Scholar
• Zhang SS, Liu JX, Zhu J, et al. Effects of TACE and preventive antiviral therapy on HBV reactivation and subsequent hepatitis in hepatocellular carcinoma: a meta-analysis. Jpn J Clin Oncol. 2019;49(7):646–655. doi:10.1093/jjco/hyz04630968933
   PubMed Web of Science ®Google Scholar
• Gu J, Zhang X, Cui R, et al. Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization. Eur J Gastroenterol Hepatol. 2019;31(7):836–844. doi:10.1097/MEG.000000000000134630614882
   PubMed Web of Science ®Google Scholar
• Ye JZ, Chen JZ, Li ZH, et al. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion. World J Gastroenterol. 2017;23(41):7415–7424.29151695
   PubMed Web of Science ®Google Scholar
• Zhao WC, Zhang HB, Yang N, et al. Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma. World J Gastroenterol. 2012;18(25):3272–3281.22783052
   PubMed Web of Science ®Google Scholar
• Chen W, Ma T, Zhang J, et al. A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma. HPB (Oxford). 2020;22(6):795–808.31980307
   PubMed Web of Science ®Google Scholar